CSF2 and neoplasm: Although we are aware that colocalization approach does not provide clear-cut evidence for the presence of nitrated-GM-CSF within the tumor core, our findings suggested that the specific targeting of the nitrated-GM-CSF might represent an effective strategy to inhibit the tolerogenic activity of the modified protein in tumors without affecting the immunostimulatory properties of the native-unmodified cytokine.